Vanda Pharmaceuticals (VNDA) Inventory Average (2012 - 2026)
Vanda Pharmaceuticals recorded quarterly Inventory Average of $10.8 million in Q1 2026, up 2.23% quarter-over-quarter from $10.5 million in Q4 2025, and up 8.75% year-over-year from $9.9 million in Q1 2025.
Vanda Pharmaceuticals' Inventory Average history runs 15 years deep, the most recent figure standing at $10.8 million for Q1 2026.
- In Q1 2026, Inventory Average rose 8.75% year-over-year to $10.8 million; the TTM figure through Mar 2026 stood at $10.8 million (up 8.75% YoY), while the FY2025 annual figure was $10.3 million, up 88.9% from the prior year.
- Inventory Average came in at $10.8 million for Q1 2026 at Vanda Pharmaceuticals, up from $10.5 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $11.3 million in Q4 2022 to a low of $1.2 million in Q1 2022.
- A 5-year average of $7.0 million and a median of $6.3 million in 2022 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average plunged 84.91% in 2024 and jumped 561.6% in 2025, its largest moves.
- Vanda Pharmaceuticals' Inventory Average stood at $11.3 million in 2022, then sank by 48.55% to $5.8 million in 2023, then retreated by 4.08% to $5.6 million in 2024, then jumped by 89.26% to $10.5 million in 2025, then rose by 2.23% to $10.8 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $10.8 million, $10.5 million, and $10.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | 10.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.76 Mn |
| Dec 31, 2025 | 10.53 Mn |
| Sep 30, 2025 | 10.20 Mn |
| Jun 30, 2025 | 10.32 Mn |
| Mar 31, 2025 | 9.90 Mn |
| Dec 31, 2024 | 5.56 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 5.69 Mn |
| Mar 31, 2024 | 5.64 Mn |
| Dec 31, 2023 | 5.80 Mn |
| Sep 30, 2023 | 10.21 Mn |
| Jun 30, 2023 | 5.64 Mn |
| Mar 31, 2023 | 6.30 Mn |
| Dec 31, 2022 | 11.27 Mn |
| Sep 30, 2022 | 6.28 Mn |
| Jun 30, 2022 | 1.39 Mn |
| Mar 31, 2022 | 1.16 Mn |
| Dec 31, 2021 | 4.60 Mn |
| Sep 30, 2021 | 7.91 Mn |
| Jun 30, 2021 | 4.50 Mn |
| Mar 31, 2021 | 1.32 Mn |
| Dec 31, 2020 | 3.99 Mn |
| Sep 30, 2020 | 5.32 Mn |
| Jun 30, 2020 | 2.62 Mn |
| Mar 31, 2020 | 1.23 Mn |
| Dec 31, 2019 | 1.08 Mn |
| Sep 30, 2019 | 1.04 Mn |
| Jun 30, 2019 | 1.08 Mn |
| Mar 31, 2019 | 1.05 Mn |
| Dec 31, 2018 | 940,500.00 |
| Sep 30, 2018 | 1.04 Mn |
| Jun 30, 2018 | 1.10 Mn |
| Mar 31, 2018 | 925,500.00 |
| Dec 31, 2017 | 880,500.00 |
| Sep 30, 2017 | 831,500.00 |
| Jun 30, 2017 | 779,000.00 |
| Mar 31, 2017 | 797,500.00 |
| Dec 31, 2016 | 822,000.00 |
| Sep 30, 2016 | 896,000.00 |
| Jun 30, 2016 | 932,500.00 |
| Mar 31, 2016 | 1.12 Mn |
| Dec 31, 2015 | 2.55 Mn |
| Sep 30, 2015 | 4.38 Mn |
| Jun 30, 2015 | 5.09 Mn |
| Mar 31, 2015 | 5.19 Mn |
| Dec 31, 2014 | 2.89 Mn |
| Sep 30, 2014 | 608,000.00 |
| Jun 30, 2014 | 400,000.00 |
| Jun 30, 2013 | 24,500.00 |
| Mar 31, 2013 | 39,000.00 |
| Dec 31, 2012 | 109,000.00 |
| Sep 30, 2012 | 163,000.00 |